DeuterOncology NV
www.deuteroncology.comDeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.
Read more
DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.
Read more
Country
City (Headquarters)
Liège
Industry
Employees
1-10
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Director of Operations
Email ****** @****.comPhone (***) ****-****Business Development Consultant
Email ****** @****.comPhone (***) ****-****
Reach decision makers at DeuterOncology NV
Free credits every month!
DeuterOncology NV FAQ
Liège, Belgium
Biotechnology Research
